PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR

AFRICAN SWINE FEVER VACCINE COMPOSITION

VACCINE FOR PREVENTING AFRICAN SWINE FEVER, COMPRISING AFRICAN SWINE FEVER VIRUS-DERIVED ANTIGEN PROTEIN

LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE

PRODUCTION METHOD AND DETECTION METHOD OF AFRICAN SWINE FEVER VIRUS

Attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion of gene and use thereof

Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof

Cocktail Vaccine of Recombinant African Swine Fever Virus (ASFV) Antigen and Use Thereof

AFRICAN SWINE FEVER VIRUS CHIMERIC PROTEIN, VACCINE COMPOSITION, PREPARATION METHOD AND USE THEREOF

Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

AFRICAN SWINE FEVER VIRUS VACCINE

Immunogenic compositions and vaccines comprising African swine fever virus peptides and proteins and uses thereof

Attenuated african swine fever virus vaccine

Attenuated African swine fever virus vaccine

Antiviral peptides from african swine fever virus which prevent the binding of the virus to DLC8

TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF

USE OF HEMAGGLUTININ OF THE AFRICAN SWINE FEVER VIRUS AS AN ADJUVANT

Preventive and Therapeutic Use of polypeptides from African Swine Virus as Vaccines

Polypeptides from African Swine Fever virus as vaccines for preventive and therapeutic use

Preventive and therapeutic use of polypeptides from African Swine virus as vaccines